Webber Elizabeth, Li Lian, Chin Lih-Shen
Department of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322-4218, USA.
J Mol Biol. 2008 Oct 10;382(3):638-51. doi: 10.1016/j.jmb.2008.07.045. Epub 2008 Jul 25.
Hypertonia, which is characterized by stiff gait, abnormal posture, jerky movements, and tremor, is associated with a number of neurological disorders, including cerebral palsy, dystonia, Parkinson's disease, stroke, and spinal cord injury. Recently, a spontaneous mutation in the gene encoding trafficking protein, kinesin-binding 1 (Trak1), was identified as the genetic defect that causes hypertonia in mice. The subcellular localization and biological function of Trak1 remain unclear. Here we report that Trak1 interacts with hepatocyte-growth-factor-regulated tyrosine kinase substrate (Hrs), an essential component of the endosomal sorting and trafficking machinery. Double-label immunofluorescence confocal studies show that the endogenous Trak1 protein partially colocalizes with Hrs on early endosomes. Like Hrs, both overexpression and small-interfering-RNA-mediated knockdown of Trak1 inhibit degradation of internalized epidermal growth factor receptors through a block in endosome-to-lysosome trafficking. Our findings support a role for Trak1 in the regulation of Hrs-mediated endosomal sorting and have important implications for understanding hypertonia associated with neurological disorders.
张力亢进表现为步态僵硬、姿势异常、动作急促和震颤,与多种神经系统疾病相关,包括脑瘫、肌张力障碍、帕金森病、中风和脊髓损伤。最近,编码运输蛋白驱动蛋白结合蛋白1(Trak1)的基因中的自发突变被确定为导致小鼠张力亢进的遗传缺陷。Trak1的亚细胞定位和生物学功能仍不清楚。在此,我们报告Trak1与肝细胞生长因子调节的酪氨酸激酶底物(Hrs)相互作用,Hrs是内体分选和运输机制的重要组成部分。双标记免疫荧光共聚焦研究表明,内源性Trak1蛋白与Hrs在早期内体上部分共定位。与Hrs一样,Trak1的过表达和小干扰RNA介导的敲低均通过阻断内体到溶酶体的运输来抑制内化的表皮生长因子受体的降解。我们的研究结果支持Trak1在调节Hrs介导的内体分选中的作用,并对理解与神经系统疾病相关的张力亢进具有重要意义。